0001179110-18-011143.txt : 20180906
0001179110-18-011143.hdr.sgml : 20180906
20180906160221
ACCESSION NUMBER: 0001179110-18-011143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180904
FILED AS OF DATE: 20180906
DATE AS OF CHANGE: 20180906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bosley Katrine
CENTRAL INDEX KEY: 0001592469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 181057572
MAIL ADDRESS:
STREET 1: C/O EDITAS MEDICINE
STREET 2: 11 HURLEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
edgar.xml
FORM 4 -
X0306
4
2018-09-04
0
0001650664
Editas Medicine, Inc.
EDIT
0001592469
Bosley Katrine
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
1
1
0
0
President and CEO
Common Stock
2018-09-04
4
S
0
10787
32.27
D
1254179
D
Common Stock
2018-09-04
4
S
0
1213
33.07
D
1252966
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
This transaction was executed in multiple trades at prices ranging from $31.79 to $32.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $32.79 to $33.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Katrine Bosley
2018-09-06